Bico Group Ab Stock Fundamentals
| BCCOY Stock | USD 0.88 0.00 0.00% |
BICO Group AB fundamentals help investors to digest information that contributes to BICO Group's financial success or failures. It also enables traders to predict the movement of BICO Pink Sheet. The fundamental analysis module provides a way to measure BICO Group's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BICO Group pink sheet.
BICO |
BICO Group AB Company Current Valuation Analysis
BICO Group's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current BICO Group Current Valuation | 766.24 M |
Most of BICO Group's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BICO Group AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, BICO Group AB has a Current Valuation of 766.24 M. This is 94.67% lower than that of the Healthcare sector and 93.83% lower than that of the Medical Devices industry. The current valuation for all United States stocks is 95.39% higher than that of the company.
BICO Group AB Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining BICO Group's current stock value. Our valuation model uses many indicators to compare BICO Group value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BICO Group competition to find correlations between indicators driving BICO Group's intrinsic value. More Info.BICO Group AB is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value BICO Group by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for BICO Group's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.BICO Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BICO Group's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of BICO Group could also be used in its relative valuation, which is a method of valuing BICO Group by comparing valuation metrics of similar companies.BICO Group is currently under evaluation in current valuation category among its peers.
BICO Fundamentals
| Return On Equity | 0.0068 | |||
| Return On Asset | -0.025 | |||
| Profit Margin | 0.02 % | |||
| Current Valuation | 766.24 M | |||
| Shares Outstanding | 282.3 M | |||
| Price To Book | 0.63 X | |||
| Price To Sales | 2.37 X | |||
| Revenue | 1.26 B | |||
| Gross Profit | 1.03 B | |||
| EBITDA | 37.7 M | |||
| Net Income | (227.6 M) | |||
| Total Debt | 1.35 B | |||
| Debt To Equity | 0.26 % | |||
| Current Ratio | 2.35 X | |||
| Cash Flow From Operations | (409.2 M) | |||
| Earnings Per Share | 0.01 X | |||
| Number Of Employees | 1.18 K | |||
| Beta | 2.1 | |||
| Market Capitalization | 654.31 M | |||
| Total Asset | 9.75 B | |||
| Net Asset | 9.75 B |
About BICO Group Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BICO Group AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BICO Group using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BICO Group AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.BICO Group AB operates as a bio convergence company in North America, Europe, Asia, and internationally. BICO Group AB was founded in 2016 and is based in Gothenburg, Sweden. Bico Group is traded on OTC Exchange in the United States.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for BICO Pink Sheet Analysis
When running BICO Group's price analysis, check to measure BICO Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BICO Group is operating at the current time. Most of BICO Group's value examination focuses on studying past and present price action to predict the probability of BICO Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BICO Group's price. Additionally, you may evaluate how the addition of BICO Group to your portfolios can decrease your overall portfolio volatility.